Erick Lucera

Chief Financial Officer

CFO Board Member Chief Accounting Officer Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Dyne Therapeutics, Inc. (DYN)	Chief Financial Officer	$391,970	—	$691,406	$1,408,214	$197,600	$6,796	$2,695,986
2024	Editas Medicine, Inc. (EDIT)	Former Executive Vice President and Chief Financial Officer	$482,600	—	$350,176	$733,711	$234,544	$8,290	$1,809,321
2023	Editas Medicine, Inc. (EDIT)	Former Executive Vice President and Chief Financial Officer	$285,615	—	$748,619	$1,034,512	$146,076	$794	$2,215,616

Resigned Executive Vice President, Chief Financial Officer at Editas Medicine, Inc. (EDIT)
2025-03-28
Appointed principal accounting officer at Dyne Therapeutics, Inc. (DYN)
2025-03-31
Appointed Chief Financial Officer and Treasurer at Dyne Therapeutics, Inc. (DYN)
2025-03-31
Resigned Board of Directors at Bone Biologics Corp (BBLG)
2023-12-27
Resigned director at Bone Biologics Corp (BBLG)
2024-01-02
Appointed director at SAB Biotherapeutics, Inc. (SABS)
2023-04-03